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Abstract 
 
Background: Diabetes is a serious disease affects human health. Diabetes in advanced stages is accompanied by general 
weakness and alteration in fats and carbohydrates metabolism. Recently there are some scientific trends about the usage of 
camel milk (CM) in the treatment of diabetes and its associated alterations. CM contains vital active particles with insulin 
like action that cure diabetes and its complications but how these effects occur, still unclear. 
Materials and Methods: Seventy-five adult male rats of the albino type divided into five equal groups. Group 1 served as 
a negative control (C). Group 2 was supplemented with camel milk (CM). Diabetes was induced in the remaining groups 
(3, 4 and 5). Group 3 served as positive diabetic control (D). Group 4 served as diabetic and administered metformin 
(D+MET). Group 5 served as diabetes and supplemented with camel milk (D+CM). Camel milk was supplemented for two 
consecutive months. Serum glucose, leptin, insulin, liver, kidney, antioxidants, MDA and lipid profiles were assayed. 
Tissues from liver and adipose tissues were examined using RT-PCR analysis for the changes in mRNA expression of 
genes of carbohydrates and lipid metabolism. Pancreas and liver were used for immunohistochemical examination using 
specific antibodies. 
Results: Camel milk supplementation ameliorated serum biochemical measurements that altered after diabetes induction. 
CM supplementation up-regulated mRNA expression of IRS-2, PK, and FASN genes, while down-regulated the expression 
of CPT-1 to control mRNA expression level.  CM did not affect the expression of PEPCK gene. On the other hand, 
metformin failed to reduce the expression of CPT-1 compared to camel milk administered rats. Immunohistochemical 
findings revealed that CM administration restored the immunostaining reactivity of insulin and GLUT-4 in the pancreas of 
diabetic rats. 
Conclusion: CM administration is of medical importance and helps physicians in the treatment of diabetes mellitus. 
 
Keywords: Camel milk, Diabetes, Gene expression, Immunohistochemistry. 
 
Abbreviations: STZ: Streptozotocin; MET: metformin; CM: Camel milk; GLUT4: glucose transporter4; FASN: fatty 
acid synthases; CPT-I: carnitine palmitoyl transferase I; PEPCK: phosphoenolpyruvate carboxykinase; PK: pyruvate 
kinase; IRS-2: Insulin receptor substrate 2; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; T1D: type-1-diabetes; 
T2D: type-2-diabetes; TC: total cholesterol; TG: triglycerides; HDL: high-density lipoproteins; CAT: catalase; GR: 
glutathione reductase; SOD: superoxide dismutase; MDA: malondialdehyde; GPT: glutamic-pyruvic transaminases; 
GOT: glutamic-oxalacetic transaminases; PBS: phosphate-buffer saline. 
 
Introduction 
 
Diabetes mellitus type 1 (T1D) is a complex disease resulting from the interplay of genetic, endocrine, epigenetic, 
and environmental factors (Hakonarson and Grant 2011). Worldwide, the T1D represents an increasing global public health 
burden, and the incidence of T1D among humans has been rising (Forlenza and Rewers 2011). Over the last few decades, 
there has been an overall increase in the incidence of T1D of ∼3% to 5% per year, and it is estimated that there are ∼65 000 
new cases per year in children, 15 years old (Borchers et al 2010). Moreover, the number of peoples with diabetes will rise 
to 500 million within the next 20 years (Malik et al 2012). Africa will experience a largest increase in the next generation 
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for diabetes incidence. But till now Middle East is characterized with high incidence of diabetes but Africa still the most 
affected (Al-Baghli et al 2011). 
Failure to control insulin level in our bodies is the leading cause of diabetes. Only 5%-10% of diabetic patients do 
not produce insulin because of complete destruction in pancreatic β-cells that results in hyperglycemia and ketoacidosis in 
type-1 diabetic patients (Gaba et al 2015). Type 2 diabetes (T2D), a non-insulin-dependent diabetes mellitus, is associated 
with insulin resistance as cells of the body can't respond to insulin. Accidental drug treatments such as glucocorticoids, β-
adrenergic agonists, statins, Streptozotocin (STZ), and alloxan induce diabetes. STZ and alloxan are used to induce diabetes 
in rodent lab animal models (Eleazu et al 2013). The pancreatic β-cells take up the STZ via the plasma membrane GLUT2 
transporter2, resulting in inflates, and ultimately irreversible destroys the pancreatic β-cells (Eleazu et al 2013; Ikebukuro et 
al 2002; Akbarzadeh et al 2007; Muhammad and Syed 2010; Sboui et al 2010; Sharma et al 2012). STZ treatment induces 
T1D (Muhammad and Syed 2010), and may induce T2D (Arulmozhi et al 2004; Martha et al 2009). 
Camel milk has valuable therapeutic effects on treatment of wounds as it enhance wound healing and increase 
immune cell proliferation and chemotaxis state of experimental animals (Badr 2012 and 2013; Badr et al 2011 and 2012). 
Presence of peptides and proteins in camel’s milk are the cause of its biological in digestion, absorption, growth and 
immunity (Korhonen and Pihlanto 2001). The most important uses of camel’s milk are as drug against autoimmune 
diseases, dropsy, jaundice, splenomegaly, asthma, anemia, piles and diabetes with antimicrobial and antitoxic effects 
(Soliman et al 2015). The improvement in immune function using dietary antioxidants as camel whey can play an important 
role in the prevention of many human diseases and diabetic complications. Dietary whey supplementations may improve 
wound healing by increasing GSH synthesis and cellular antioxidant defense (Velioglu Ogünç et al 2008). As known, 
camel milk contains insulin-like peptides and other substances that modulate glucose level (Mohamad et al 2009; Zagòrski 
et al 1998; Agrawal et al 2003). 
There is a growing worldwide trend that camel milk consumption helps in prevention and control of diabetes 
(Malik et al 2012). The presence of peptides in camel’s milk exhibits its biological activities that have a valuable effect on 
digestion, absorption, growth and immunity (Korhonen and Pihlanto 2001) and antitoxic effect against some heavy metals 
and drugs (Al-Hashem 2009; Afifi 2010; Khan and Alzohairy 2011). CM is beneficial in reducing the dose of insulin 
needed to induce glycemic control and improves fasting blood glucose, glycosylated hemoglobin, serum anti-insulin 
antibodies, urinary albumin excretion, and mass body index (Agrawal et al 2009; Mohamad et al 2009). Regular 
consumption of CM for few months improved the condition of diabetic patients and experimental animal models (Sboui et 
al 2010; Mohamad et al 2009; Agrawal et al 2005 and 2011). Most published data about the way by which any treatment 
may affect the response of diabetic patients and experimental animal models is not completely explained (Mima et al 2008; 
WHO 2011; Hesham et al 2012).  Therefore, this study focused on examining the changes in biochemical alterations during 
diabetes, changes in gene expression of lipids and carbohydrate metabolism and how to prevent or modulate diabetes 
incidence by camel milk supplementation. Moreover, the histopathological changes using immunohistochemical stains for 
pancreas was used to clarify the medical importance of CM supplementation in treatment of diabetes. 
 
Materials and Methods 
Camel's milk preparation 
 
Camel’s milk samples were collected daily in the morning from camel farm in Turabah governorate, Mecca 
princedom, KSA. Milk was collected from healthy camels (4 years old) by hand milking and kept in sterile screw bottles 
and kept under cooling conditions until transported to the laboratory. Rats supplemented with unpasteurized camel milk. 
 
Experimental Design 
 
Seventy-five adult male rats of the albino type, 8 weeks old, 200 gram body weight were purchased from King 
Fahd center for Scientific Research, King Abdel-Aziz University, Jeddah, KSA. Rats were kept for one week for 
acclimatization. All animal procedures were approved by the Ethical Committee Office of the dean of scientific affairs of 
Taif University, Saudi Arabia. Rats were divided into five groups (each group were handled in triplicate; 5 rats per one cage 
in triplicate; 15 rat per group). Group 1 as used as a control and received free access to food and water. Group 2 
supplemented with camel milk (CM). Diabetes was induced in the remaining forty-five rats by intraperitoneal injection of 
STZ (60 mg/kg bw, Sigma-Aldrich St. Louis, MO, USA) based on protocol stated by Saleh et al (2016). To avoid the 
sudden death of the diabetic rats due to hypoglycemia, rats were supplemented with 5% glucose solution for the next 12 h 
following STZ injection. Diabetes was confirmed after 72 hrs of STZ injection by measuring blood glucose levels using 
commercially available glucose detector. Rats with glucose levels over 220 mg/dL considered diabetic and used for 
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subsequent groups. The positive diabetic rats divided into groups 3, 4 and 5. Group 3 served as positive diabetic control 
(D). Group 4 diabetic and administered metformin (D+MET). Group 5 served as diabetes and supplemented with CM 
(D+CM). CM was given orally to group 2 and 4 at a dose of 250 ml /24 hours/15 rats based on study of Althnaian 
(Althnaian et al 2013).  CM dose can be equated as 83.33 ml /kg bw daily for 2 consecutive months. The experiment was 
repeated three times each time with five animals for reproductively. Twenty-four hours after last administrations, all rats 
were sacrificed after anesthetization by diethyl ether inhalation. Blood, liver, and adipose tissues were collected. Liver and 
adipose tissues were kept in TRIzol® reagent (Life Technologies, USA) at -80°C in a deep freezer for ribonucleic acid 
(RNA) extraction and maintained in 10% neutral buffered formalin (NBF) at room temperature for 24 hours for 
immunohistochemical study. 
 
Serum biochemical measurements 
 
Triglycerides (TG), total cholesterol (TC), and high-density lipoproteins (HDL) were measured using commercial 
spectrophotometric analysis kits (Bio-Diagnostic Company, Giza, Egypt). Insulin and leptin levels were measured using 
spectrophotometric commercial kits bought from Chrystal Chem Co, Downers Grove, IL 6051 USA. Glucose was 
measured using commercial glucose monitoring set (ACCU-Chek). Liver, renal biomarkers, antioxidants and MDA were 
measured spectrophotometrically as indicated in instruction manuals of each kit. 
 
RNA Extraction  
 
Total RNA was extracted from adipose and liver tissues samples as stated previously (Ahmed and Ahmed 2016). 
RNA concentration and purity determined by BIO-RAD SmartSpecPlus UV/Visible Spectrophotometer (USA). RNA 
integrity was examined by running through 1.5% denaturated agarose gel stained with ethidium bromide.  
 
Semi-quantitative RT-PCR analysis 
 
Three micrograms of total RNA and 0.5 ng oligo dT primer (Qiagen Valencia, CA, USA) were used for cDNA 
synthesis. The total volume was adjusted up to 11 µl by sterilized DEPC water and incubated in the Bio-Rad T100TM 
Thermal cycler at 65°C for 10 min for denaturation. Then, 2 µl of 10X RT-buffer, 2 µl of 10 mM dNTPs and 100U 
Moloney Murine Leukemia Virus (M-MuLV) Reverse Transcriptase (Sib Enzyme. Ak, Novosibirsk, Russia) were added. 
The total volume was adjusted up to 20 µl by adding DEPC water. The mixture was then kept in BIO-RAD thermal cycler 
at 37°C for one hour, re-heated for 10 min at 90°C for enzyme deactivation. Specific primers for examined genes (Table 1) 
were designed using Primer3Plus online software (http://primer3plus.com/) and synthesized by Macrogen (Macrogen 
Company, Korea). 1 µl cDNA was mixed with 1 µl of 10 pm of each primer, and 12.5 µl PCR master mix (Promega USA). 
The final volume was brought up to 25 ml using sterilized, deionized water. PCR was carried out using Bio-Rad 
T100TM Thermal Cycler with a cycle sequence at 94°C for 5 minutes one cycle, followed by 31 cycles (Table 1) each of 
which consists of denaturation at 94 °C for one minute, annealing at the specific temperature corresponding to each primer 
(Table 1) and extension at 72 °C for one minute with an additional final extension at 72 °C for 7 minutes. Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) mRNA was used as a reference. The PCR products were electrophoresed on 1.5% 
agarose gel, stained with 0.1μg/ml of ethidium bromide. PCR products were photographed and subjected to band intensity 
analysis using Image J software v. 1.47 (http://imagej.en.softonic.com/). 
 
Table (1): PCR conditions and primers sequence of examined genes. 
 
 
 
  
 
 
 
 
 
 
 
Gene Primer sequence (5'-3')  Annealing Temp. Band size 
GAPDH 
AGATCCACAACGGATACATT (F) 
52 309 bp 
TCCCTCAAGATTGTCAGCAA (R) 
PK 
ATTGCTGTGACTGGATCTGC (F) 
52 229 bp 
CCCGCATGATGTTGGTATAG (R) 
PEPCK 
TTTACTGGGAAGGCATCGAT (F) 
52 236 bp 
TCGTAGACAAGGGGGCAC (R) 
IRS-2 
CTACCCACTGAGCCCAAGAG (F) 
55 151 bp 
CCAGGGATGAAGCAGGACTA (R) 
FASN 
CCAGAGCCCAGACAGAGAAG (F) 
61 345bp 
GACGCCAGTGTTCGTTCC (R) 
CPT-1 
TATGTGAGGATGCTGCTTCC (F) 
52 628 bp 
CTCGGAGAGCTAAGCTTGTC (R) 
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Immunohistochemical analysis of pancreatic insulin  
 
Rat Pancreas was fixed in 10% buffered neutral formalin then washed, dehydrated in ascending grades of ethyl 
alcohol then cleared in xylene, embedded in paraffin, sectioned at 5 micron thickness, deparaffinized, and then treated with 
3% H2O2 for 10 min to block the peroxidases activity. Subsequently, the tissue samples were heated at 121oC in 10 mM 
citrate buffer for 30 min, blocked for 20 min in 5% normal serum. The pancreatic tissue was incubated overnight with 
rabbit polyclonal anti-insulin primary antibody (1:100; sc-9168; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) or with 
GLUT4 Antibody (1:100; sc-53566; Santa Cruz Biotechnology, Inc., Dallas, TX, USA) in phosphate-buffered saline (PBS) 
at 4˚C. After three extensive washes with PBS, the sections were incubated with a goat anti-rabbit IgG biotin conjugated 
secondary antibody (1:2,000; sc-2040; Santa Cruz Biotechnology, Inc.) for 20 min at 32˚C. After further incubation with 
horseradish peroxidase-labeled streptavidin, antibody binding was visualized using diaminobenzidine, and the sections 
were counterstained with hematoxylin. 
 
Statistical analysis 
 
Data are presented as means ± standard error of means (SEM) for 3 independent experiments per each treatment. 
Results were analyzed using analysis of variance (ANOVA) and post hoc descriptive tests by SPSS software v 11.5 (SPSS, 
IBM, Chicago, IL, USA) with p<0.05 regarded as statistically significant.  
 
Results 
Analysis of serum chemistry in diabetic rats: 
Effect of camel milk supplementation on glucose, insulin and leptin levels in diabetic rats 
 
Diabetic rats supplemented with camel milk showed a decrease in glucose levels compared to diabetic rats (D). 
This is coincided with the decrease reported in metformin administered diabetic rats (D+MET) as a positive therapeutic 
group. The changes in glucose levels are mainly due to the increase in insulin secretion reported in camel milk administered 
diabetic rats (D+CM) as seen in the Table (2). Leptin levels were decreased in diabetic group and was increased in 
metformin diabetic rats (D + MET) while CM administration normalized and increased it in a way to increase peripheral 
glucose utilization and homeostasis (D+CM) as seen in table 2. 
Table (2): serum changes in glucose levels, insulin and leptin in diabetic rats and after camel milk administration for 2 
months 
Group Glucose  
(mg/dL) 
Insulin 
 (µU/ml) 
Leptin  
(ng/ml) 
Control (C) 83.09.7 35.32.3 12.63.1 
Diabetes (D) 462.337.8* 8.30.5* 9.15.1* 
Diabetes + metformin (D+MET) 120.010.1# 27.23.4# 17.25.3# 
Control + Camel milk (CM) 85.75.8 39.36.3 10.01.6 
Diabetes + Camel milk (D+CM) 96.711.1# 332.3# 10.41.3# 
Values are means ± standard error (SEM) for 3 independent experiments per each treatment. Values are statistically 
significant at *p<0.05 Vs. control; #p<0.05 Vs. diabetic group #p<0.05 Vs. diabetic metformin group. 
 
Effect of camel milk supplementation on kidney and liver biomarkers in diabetic rats 
 
Due to oxidative stress induced by diabetes, diabetic rats showed significant an increase in serum levels of urea, 
creatinine, GPT and GOT (Table 3). Administration of camel milk to diabetic rats (D+CM) normalized these changes. The 
results reported for camel milk in diabetic rats are the same reported for control positive metformin administered rats 
(D+MET). 
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Table (3): Serum changes in kidney and liver function parameters in diabetic rats and after camel milk administration for 2 
months. 
Group Urea (mg/dL) Creatinine (mg/dL) GPT  
(U/L) 
GOT 
 (U/L) 
Control (C) 43.09.2 0.80.1 103.67.7 90.67.6 
Diabetes (D) 111.714.8* 2.40.2* 169.115.1* 181.15.1* 
Diabetes + metformin 
 (D+ME) 
69.022.4# 1.10.3# 99.225.3# 121.714.9# 
Control + Camel milk  
(C+CM) 
40.75.8 0.90.2 86.02.5 96.016.3 
Diabetes + Camel milk  
(D+CM) 
66.28.5# 0.70.02# 103.724.2# 70.713.0# 
Values are means ± standard error (SEM) for 3 independent experiments per each treatment. Values are statistically 
significant at *p<0.05 Vs. control; #p<0.05 Vs. diabetic group #p<0.05 Vs. diabetic metformin group. GPT; glutamate 
pyruvate transaminase; GOT; Glutamic-oxaloacetate transaminases. 
 
Effect of camel milk supplementation on oxidative stress and antioxidants levels of diabetic rats 
 
The changes in malondialdehyde (MDA) levels are seen in table 4. Diabetic rats showed an increase in MDA 
levels and CM administration normalized MDA levels in CM administered diabetic rats (Table 4). Catalase (CAT), 
glutathione reductase (GR), and superoxide dismutase (SOD) were decreased in diabetic rats. The percent decrease in 
antioxidant enzymes were about 71% compared to control group (C). Antioxidants levels were normalized in diabetic rats 
after CM supplementation (D+CM; table 4).  
 
 
Table (4): Serum changes in MDA and antioxidants levels in diabetic rats and after camel milk administration for 2 
months. 
Group MDA 
(nmol/g tissue) 
CAT 
(U/g tissue) 
GR 
(U/g tissue) 
SOD 
(U/g tissue) 
Control (C) 4.50.1 31.42.0 9.40.4 11.50.3 
Diabetes (D) 28.51.8* 8.70.5* 3.10.1* 2.90.2* 
Diabetes + metformin (D+ME) 14.13.8# 26.42.4# 7.51.0# 9.81.2# 
Control + Camel milk (C+CM) 11.64.0 31.46.1 9.40.4 10.71.0 
Diabetes + Camel milk (D+CM) 8.30.3 32.31.8# 9.80.3# 11.40.5# 
Values are means ± standard error (SEM) for 3 independent experiments per each treatment. Values are statistically 
significant at *p<0.05 Vs. control; #p<0.05 Vs. diabetic group #p<0.05 Vs. diabetic metformin group. (GR); Glutathione 
reductase, (MDA); malondialdehyde, (CAT); Catalase, (SOD); super oxide dismutase. 
 
Effect of camel milk supplementation on total cholesterol, triglycerides and high density lipoproteins in diabetic rats 
 
A significant increase in the total cholesterol (TC), triglycerides (TG) and a decrease in high-density lipoproteins 
(HDL) levels were reported in diabetic rats.  Camel milk administration ameliorated and normalized the increase in TC and 
TG levels in diabetic rats (D+CM). In parallel, CM supplementation increased HDL levels compared to diabetic group 
alone. The ameliorated effect induced by camel milk is relatively the same reported for metformin administered rats 
(D+MET) as seen in table 5.  
Table (5): Serum changes in lipid parameters in diabetic rats and after camel milk administration for 2 months 
Group TC (mg/dL) TG (mg/dL) HDL(mg/dL) 
Control (C) 93.710.2 53.32.8 19.70.9 
Diabetes (D) 252.718.2* 128.311.8* 8.94.1* 
Diabetes + metformin (D+ME) 161.221.8# 85.79.1# 16.20.6# 
Control + Camel milk (C+CM) 104.719.2 77.79.8 20.30.9 
Diabetes + Camel milk (D+CM) 100.06.6# 72.30.5# 15.72.2# 
Values are means ± standard error (SEM) for 3 independent experiments per each treatment. Values are statistically 
significant at *p<0.05 Vs. control; #p<0.05 Vs. diabetic group #p<0.05 Vs. diabetic metformin group. (TC) total 
cholesterol, (TG) triglycerides, (HDL) high density lipoprotein. 
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Effect of camel milk supplementation on hepatic gene expression of carbohydrates and lipids metabolism in diabetic 
rats 
 
The effect of camel milk on the expression of some genes related to carbohydrate and lipid metabolism altered 
during diabetes are shown in Figs (1 and 2). As shown in figure 1, CM administration alone did not affect the expression of 
PEPCK gene in diabetic group (D+CM). The mRNA expression of IRS-2 gene was down-regulated in diabetic rats (D) and 
increased in positive metformin diabetic rats (D+MET). CM administration increased significantly mRNA expression of 
IRS-2 in CM administered diabetic rats (D+CM) in parallel with results reported for metformin diabetic group. A similar 
change in mRNA expression of PK occurred and was the same like in IRS-2 gene. On the other hand, figure 2 shows that 
the expression of CPT-1 was increased due to diabetic rats (D). Metformin administration failed to inhibit the up-regulation 
occurred in diabetic rats. Interestingly, CM administration restored the expression level of CPT-1 to normal levels as 
compared to control group (C). Moreover, CM supplementation up-regulated the transcription of FASN mRNA in diabetic 
rats (D+CM) in same pattern reported for metformin diabetic rats (Figure 2). 
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Figure 1: Semi-quantitative RT-PCR analysis of PEPCK, 
PK and IRS-2 mRNA expressions and their 
corresponding GAPDH in the rat liver tissue. RNA was 
extracted and reverse-transcribed (3 μg), and RT-PCR 
analysis was carried out for examined genes as described 
in the Materials and methods. Densitometric analysis 
was carried for 15 different rats per each group. Values 
are means ±SEM obtained from 5 rats in triplicate per 
group. *P<0.05 vs. control group, and #P<0.05 vs. 
diabetic group. 
 
Figure 2: Semi-quantitative RT-PCR analysis of CPT-1 
and FASN mRNA expressions and their corresponding 
GAPDH in the rat adipose tissue. RNA was extracted 
and reverse-transcribed (3 μg), and RT-PCR analysis 
was carried out for examined genes as described in the 
Materials and methods. Densitometric analysis was 
carried for 15 different rats per each group. Values are 
means ± SEM obtained from 5 rats in triplicate per 
group. *P<0.05 vs. control group, and #P<0.05 vs. 
diabetic group. 
 
Immunohistochemical analysis of pancreatic insulin after camel milk supplementation in diabetic rats 
 
The pancreas of control rats showed normal tissue architecture with regular insulin expression in the pancreatic β-
cells (Fig. 3A).  CM and metformin administered control rats (C+CM) and (C+MET) showed normal insulin expression in 
pancreatic beta cells (Figs. 3B & 3C respectively). The pancreatic tissue from diabetic rats (D) exhibited a reduction in the 
expression of insulin, with atrophy of the pancreatic β-cells (Fig. 3 D). Finally, the pancreas of CM administered diabetic 
rats (D+CM) exhibited regenerative restoration of normal expression of insulin in the pancreatic β-cells (Fig. 3 E). On the 
same line, pancreas of control rats (C) presented normal GLUT4 expression in the pancreatic tissues (Fig. 3F). CM and 
metformin aministered control rats (C+CM) and (C+MET) showed normal GLUT-4 expression in pancreatic tissue (Figs. 
3G & 3H respectively). However, the pancreatic tissue from diabetic rats (D) exhibited a reduction in the expression of 
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GLUT4 (Fig. 3I) while the pancreas of the group (D+CM) exhibited restoration of normal expression of GLUT4 in the 
pancreatic tissue (Fig. 3J). 
 
 
Figure 3: (A): Pancreatic tissue of a healthy control rat showing a normal architecture with normal expression of insulin in 
the βcells (magnification, x1200). (B): Pancreatic tissue of camel milk administered rat showing normal expression of 
insulin in the β cells. (C): Pancreatic tissue of metformin administered rat showing normal insulin expression in the β cells. 
(D): Pancreatic tissue of streptozotocin administered rat showing a reduction in the expression of insulin in the βcells, with 
atrophy of the βcells (magnification, x1200). (E): Pancreatic tissue of Streptozotocin administered rat treated with camel 
milk showing the restoration of normal expression of insulin in the pancreatic βcells (magnification, x1200). (F): the 
pancreas of the healthy control rats presented normal GLUT-4 expression in the pancreatic tissue (magnification, x150). 
(G): The pancreas of camel milk administered rats showed normal expression of GLUT-4 in the pancreatic tissue 
(magnification, x150). (H): The pancreas of metformin administered rats presented normal GLUT-4 expression. (I): the 
pancreatic tissue from the diabetic rats exhibited a reduction in the expression of GLUT-4 (magnification, x150). (J): the 
pancreas of the diabetic treated with camel milk exhibited restoration of normal expression of GLUT-4 in the pancreatic 
tissue (magnification, x150). Scale bar for photos from A to E is 50 μm & for photos from F to J is 100 μm.  
 
Discussion 
 
Traditional medicine is a common way used in public remedy; the desert Bedouins use different varieties of 
natural materials including animal products in treating diseases. A large number of articles mentioned the benefits of camel 
milk (Malik et al 2012; Hanieh et al 2015; Laila et al 2015). Our results showed that administration of camel milk reduced 
the levels of serum glucose and restored the average level of leptin in the treated diabetic rats because camel milk contains 
insulin nanoparticles which are protected from digestive tract proteases and absorbed directly in the intestine (Malik et al 
2012; Al-Hashem 2009; Kamal et al 2007; Abd El-Aziz et al 2012). As known, the insulin contained in camel milk has 
same features as human insulin (Malik et al 2012). Moreover, the camel milk keeps its liquidity form in the environment of 
the low stomach pH. Camel milk has an advantage, that it contains 'insulin-like' small molecule substances that mimic 
insulin interaction with its receptor, for that, it can be suitable for treating the patients who have insulin resistance (T2D) 
(Malik et al 2012). Diabetes has a strong relationship with renal and liver diseases (Mazen and John 2015). Camel milk 
protected the liver and kidney function from failure; we suppose that camel milk contains insulin nanoparticles that 
safeguard the role of kidney and liver by restoring the normal glucose levels in the blood. Previous studies (Sharma et al 
2012; Saleh et al 2016; Merecz et al 2015), reported that diabetes increases the induction of oxidative stress by elevating the 
level of MDA and decreasing antioxidant concentrations in the serum, and that coincides with our results. Zeineb et al 
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2014, investigated the antioxidant activity of camel milk and found that the casein of camel milk inactivates the reactive 
oxygen species by scavenging the free radicals. Mohamad et al (2009) and Hanieh et al (2015) evaluated the effects of 
camel milk on the TC, HDL and TG levels in T1D and T2D respectively, their findings agreed with our results that, CM 
normalized the alteration in HDL and TG, while reduced the increase in TC levels. Therefore, camel milk can give 
promising results when used as dietary supplement for patients of T1D. Insulin plays a main role in the regulation of 
PEPCK, IRS-2, CPT-1, PK and FASN gene expression (Quinn and Yeagley 2005; O'Brien et al 1990). PEPCK enzyme 
catalyzes the rate-controlling step of gluconeogenesis. Insulin is a dominant negative regulator of PEPCK gene 
transcription (Kaushik and Richard 2007). Our results showed that camel milk did not reduce the expression of PEPCK 
gene. Probably the increase in both insulin and leptin levels are the cause for this effect. As both hormones can regulate 
glucose levels, therefore, no need for the gluconeogenesis. Insulin resistance is the leading cause of T2D, which is 
correlated with reduction in expression of both major insulin receptor substrate (IRS) proteins, (IRS-1) and (IRS-2) (Fisher 
and Kahn 2003). Our results showed that camel milk provoked the activity of ISR-2 while metformin failed to achieve this 
goal. Metformin works directly on the reduction of glucose production from non-carbohydrate carbon substrates in the liver 
through gluconeogenesis metabolic pathway (Michael and Deborah 2001). The reduction of IRS-2 expression causes severe 
reduction of β-cells (Kubota et al 2000). Camel milk contains zinc, which has a key role in the insulin maturation and 
secretion in pancreatic β-cells (Gisela 2005), in addition to the presence of camel milk immunoglobulin may offer massive 
potentials by interaction with the host cell protein that cause an enhancement of regulatory cells and leads to down-
regulation of the immune system and salvage the β-cells (Agrawal et al 2007). Various published data reported that insulin 
stimulates expression of the PK gene which is responsible for the increase in hepatic glycolysis to help in peripheral 
glucose utilization (Yuuki et al 2003; Yamada and Tanaka 1999). Administration of camel milk normalized the expression 
of CPT-1 level in the diabetic rats, reduced the TG levels to normal levels and elevated the levels of high-density 
lipoprotein cholesterol (HDL). There is an inverse relationship between CPT-1 expression and triglycerides content in the 
cell. Insulin reduces the expression of CPT-1 and increases glycogen and triacylglycerides synthesis. Furthermore 
administration of camel milk inhibited lipolysis associated with diabetes because the used camel milk is already non-
defatted. The FASN gene is the enzyme involved in converting acetyl-CoA into fatty acids (lipogenesis). Insulin plays a key 
role in the regulation of fatty acid synthase (FAS). It does increase the rate of FASN gene transcription and FAS enzymatic 
activity. Conversely, in the case of insulin resistance FASN is markedly inactivated (Jose et al 2010). The results showed 
that administration of camel milk enhanced the expression of FASN gene. This enhancement is referred to the insulin 
particles included in the camel milk. We boosted our investigation by the immunohistochemical test. STZ induced diabetes 
by destroying the pancreatic β-cells (Eleazu et al 2013; Sharma et al 2012). Checking the amount of produced insulin is a 
good indicator of the normal case of Langerhans islets β-cells because the active insulin is secreted from secretory granules 
in the β-cells (Agrawal et al 2007).  
Our results showed that administration of camel milk showed restoration of insulin secretion in diabetic rats; this 
means that the Langerhans islets β-cells restored their activity. There are three possibilities to explain this result; (1) 
regeneration has occurred of distorted β-cells, this explanation agrees with Srinivasan and Ramarao (2007) who mentioned 
that there is a spontaneous regeneration of damaged β-cells in the chemically induced diabetes. (2) The undamaged β-cells 
secretes insulin with overdose to compensate the shortage caused by damaged cells, (3) camel milk reduced the STZ 
damage effects occurred in the β-cells; this explanation congruent with Hamers et al. (1993). Furthermore, camel milk has 
antitoxic effects against drugs (Afifi 2010; Khan and Alzohairy 2011; Al-Fartosi et al 2011), as well as antioxidant effects 
(Zeineb et al 2014) that reduced the STZ dangerous effects. GLUT-4 is insulin-responsive glucose transporter, which 
diffuses glucose into adipose and muscular tissues (Stenbit et al 1997). We indicated that; the reduction of GLUT-4 
appeared in the diabetic rats (under immunohistochemical examination) reflects the decrease in insulin secretion. Because 
the expression of GLUT-4 is stimulated by cascade gene regulation enhanced by secretion of insulin hormone (Gisela 
2005). Administration of camel milk restored the expression of GLUT-4 in the pancreas tissue which is detected by the 
immunohistochemical staining, camel milk already contains insulin as mentioned in different articles (Malik et al 2012; Al-
Hashem 2009; Kamal et al 2007; Abd El-Aziz et al 2012) as well as it restored the activity of the β-cells as we mentioned 
previously. 
 
Conclusion 
 
Camel milk is a natural product that can be considered as a nutritional supplement that helps in treatment of 
diabetes and it metabolic associated disorders such as insulin resistance. It has dynamic effects on the regulation of CPT-I, 
FASN, PK and IRS-2 expression, stimulation of insulin production and secretion from the pancreas. CM ameliorated and 
normalized the changes in glucose, TC, TG, and HDL levels in the blood of diabetic rats. 
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